Designs multivalent glycoconjugates and glycomaterials to program lectin-immune pathways. Merges carbohydrate/medicinal chemistry, protein engineering, and nanotechnology to create glycopeptide and virus-like particle vaccines, engage antigen-presenting cells, and map structure–activity for anti-tumor immunity.